Entity coverage

Bicycle Therapeutics plc

BCYC · 2 events mapped

Market Ontology has mapped 2 distinct macro, policy, and market events to BCYC. Each entry below traces the causal channel from the driver to the assumption it moved.

Recent event impacts

Full ledger →
  • 2026-06-18EventInvestor sentiment and corporate governance. The results of shareholder votes, particularly on executive compensation, board composition, or significant corporate actions, can influence investor perception of management's alignment with shareholder interests and overall corporate governance.
  • 2026-06-12EventIncreased competitive pressure in the hereditary angioedema (HAE) market. KalVista's lead product, sebetralstat, is an oral on-demand treatment for HAE, which could compete with existing or pipeline HAE treatments.

Continuous coverage for BCYC with alerts, structural playbooks, and options routing lives in the platform. Start a trial →